Campylobacter Food Poisoning Wrecks Your Gut Bacteria, Study Finds
A case-control metagenomic study of 60 stool samples finds that Campylobacter infection - the most common form of bacterial food poisoning, usually caught from undercooked chicken - leaves a distinct fingerprint on the gut microbiome: lower diversity, fewer protective bacteria, and a shift toward inflammation-associated species, even though it does not appear to seed new antibiotic resistance genes.
Food poisoning from undercooked chicken is usually framed as a miserable few days and then it's over. A new UK study suggests the story doesn't end when the diarrhea stops: it found a distinct, measurable fingerprint left behind in the gut microbiome (the community of bacteria living in your intestines) of people infected with Campylobacter, the single most common cause of bacterial gastroenteritis. If you've ever wondered whether a bad stomach bug could have knock-on effects on your gut health, this is one of the first studies to actually map what changes, and what doesn't.
Key takeaways:
- Stool from 30 people with confirmed Campylobacter infection had significantly lower bacterial diversity than stool from 30 other symptomatic patients who tested negative for it, with a shift toward inflammation-associated bacteria and away from protective, short-chain-fatty-acid-producing species.
- Despite the disruption, the study found no evidence that infection increases the overall burden of antibiotic-resistance genes in the gut.
- This is a single, unreplicated case-control study using symptomatic (not healthy) comparison patients, so it shows an association at one snapshot in time, not proof that the infection alone caused the changes or that they're permanent.
Campylobacter Infection Lowers Gut Bacterial Diversity, Metagenomic Study Finds
Researchers at the Quadram Institute Bioscience and University of East Anglia in Norwich, UK, found that people with PCR-confirmed Campylobacter infection had markedly less diverse gut bacteria than symptomatic patients who tested negative for it. Using Shannon diversity (a standard measure of how many different species are present and how evenly balanced they are), the infected group scored a median of 2.36 versus 2.97 in the comparison group (p = 0.035) – and the raw number of detectable species was lower too (median 85.5 versus 146, p = 0.014). The two groups' overall bacterial makeup was also statistically distinct, not just less diverse. Alongside that drop, specific SCFA-producing genera like Roseburia, Blautia, and Alistipes were significantly depleted in the infected group, while families associated with gut inflammation – Enterobacteriaceae and the Campylobacter-containing Campylobacteraceae itself – expanded.
Anyone Recovering From Food Poisoning or Managing IBS Should Take Note
Campylobacter is the leading bacterial cause of food poisoning worldwide, typically picked up from raw or undercooked poultry, unpasteurized milk, or contaminated water, and the CDC estimates it sickens roughly 1.9 million people a year in the US alone. That makes this a common enough exposure that its downstream effects on gut health are worth understanding, particularly for the sizable group of people who trace ongoing digestive symptoms – bloating, irregular bowel habits, new food sensitivities – back to a stomach bug they had weeks or months earlier. Post-infectious IBS is a recognized phenomenon after bacterial gastroenteritis, and this study is one of the first to show, at the microbial level, what a Campylobacter infection specifically does to the gut community rather than just describing symptoms.
A 60-Sample Case-Control Design Using Shotgun Metagenomics
The team pulled 60 anonymized stool samples from a UK diagnostic biorepository: 30 that tested PCR-positive for Campylobacter and 30 that tested negative on a full panel screening for the other major enteric pathogens (Salmonella, Shigella, shiga toxin-producing E. coli, and two parasites). Both groups were symptomatic patients whose doctors had sent stool samples for testing – the negative group is not a healthy control group, but people with unexplained gastrointestinal symptoms. Every sample went through shotgun metagenomic sequencing (a method that reads essentially all the DNA in a sample, rather than targeting one gene, letting researchers identify species and functional genes at once), and the researchers also attempted to culture live Campylobacter from each sample, successfully recovering isolates – mostly C. jejuni – from 20 of the 30 positive samples.
What This Means If You're Trying to Rebuild Your Gut After a Bug
If you've had a confirmed Campylobacter infection, this study offers some reassurance and one open question. The reassurance: despite the visible disruption to your gut community, the researchers found no significant increase in the overall load of antibiotic-resistance genes in infected patients' gut bacteria (p = 0.79) – so the infection itself doesn't appear to be seeding your microbiome with a broader resistance problem. The open question is what happens to diversity and to those depleted SCFA-producing bacteria after the infection clears. SCFAs (short-chain fatty acids like butyrate) are what your gut bacteria make from fiber, and they're a major fuel source for the cells lining your colon and a key part of keeping that barrier intact – so a temporary dip in the bacteria that produce them is plausible as a mechanism worth watching, not a confirmed lasting injury. This study cannot tell you whether your gut recovers in days or whether it takes longer, and it doesn't establish that any specific supplement, probiotic, or diet change speeds that recovery – anyone with persistent symptoms weeks after a confirmed infection should raise it with a doctor rather than self-treat based on this finding.
The Comparison Group Wasn't Healthy, and the Study Can't Prove Direction
The most important limitation is the comparison group: the 30 "negative" patients were still symptomatic and being tested for gastroenteritis, not healthy volunteers, so some of the observed difference could reflect whatever was actually making that second group sick rather than something unique to Campylobacter. The two groups also weren't matched for age or sex – the negative group skewed older and included more women – though the researchers statistically adjusted for age and re-ran the analysis excluding young children, and the main findings held. The design is also cross-sectional: everyone was sampled once, during illness, so the study cannot say whether the dysbiosis existed before infection, how long it persists afterward, or whether it's the infection driving the community shift rather than the reverse. Finally, the researchers had no data on prior antibiotic use, which is a major driver of both gut bacteria and resistance genes, so the resistome findings in particular are associative rather than causal.
Longitudinal Sampling Is the Obvious Next Step
The authors are explicit that the next move is a longitudinal study – sampling the same patients before, during, and after infection – to establish whether the dysbiosis they documented is transient or lasts weeks to months, and whether it's a cause or a consequence of getting infected in the first place. No timeline for that follow-up work has been announced.
Common Questions
Does this mean Campylobacter infection permanently damages your gut? No – the study only sampled people during active infection, so it cannot say whether the changes are temporary or long-lasting; that requires a follow-up study that resamples the same people over time.
Is Campylobacter food poisoning linked to antibiotic-resistant bacteria? Not according to this study – it found no significant difference in overall antibiotic-resistance-gene burden between infected and non-infected patients, despite the clear shift in which bacterial species were present.
How do you avoid Campylobacter infection in the first place? Cook poultry thoroughly, avoid cross-contaminating other foods with raw chicken juices, and avoid unpasteurized milk and untreated water, per CDC guidance.
Should I take a probiotic after food poisoning to fix my gut bacteria? This study doesn't test or support any specific intervention – it only documents which bacteria drop out during infection, not what restores them, so that's a question for a doctor rather than something this research answers.
Evidence Rating
EMERGING — 71/100
Caveats
- Single case-control study; not yet replicated in an independent cohort
- The comparator (‘PCR-negative’) group was still symptomatic patients being tested for gastroenteritis, not healthy people – so some of the difference could reflect other undiagnosed causes of illness rather than Campylobacter specifically
- No matching by age or sex between groups; the PCR-negative group skewed older and more female, though statistical adjustment did not change the main results
- Cross-sectional design: stool was sampled only during illness, so it cannot show whether the dysbiosis existed beforehand, how long it lasts, or whether the gut recovers
- Resistome findings are descriptive/associative only – no data on prior antibiotic use was available to rule out as a confound
A single UK case-control study (60 stool samples, shotgun metagenomics) found significantly lower gut bacterial diversity and depleted short-chain-fatty-acid producers in Campylobacter-PCR-positive patients versus symptomatic PCR-negative controls, with no corresponding rise in antibiotic-resistance-gene burden. The comparison group was other symptomatic patients, not healthy controls, and the design is cross-sectional and unreplicated, so the findings describe an association at one point in time rather than proof that Campylobacter alone caused the changes or that they persist.
References
- Bilal Djeghout, Alise J. Ponsero, Nuno Pedroso, George M. Savva, Ngozi Elumogo, Nicol Janecko (2026). Gut microbiome dysbiosis and functional alterations in Campylobacter -associated gastroenteritis using metagenomic approaches. Gut Microbes Reports. https://doi.org/10.1080/29933935.2026.2688065
- Ziyang Zhan, Hao Tang, Ying Zhang, Xinxiang Huang, Min Xu (2022). Potential of gut-derived short-chain fatty acids to control enteric pathogens. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2022.976406
- About Campylobacter Infection – CDC. cdc.gov. https://www.cdc.gov/campylobacter/about/index.html